Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of EV06 Ophthalmic Solution in Improving Vision in Subjects With Presbyopia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating EV06 ophthalmic solution for improving vision in presbyopia has completed, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Presbyopia

Drugs mentioned

• EV06 ophthalmic solution (EV06)

Snippet

Sponsor: Encore Vision, Inc. | Conditions: Presbyopia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-04-21